Eko Analysis Software vs Us2.v2
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A assists clinicians in early detection of cardiovascular diseases like heart murmurs and atrial fibrillation by analyzing heart sounds and ECGs from digital stethoscopes. Tool B, on the other hand, automates the interpretation of echocardiograms to deliver comprehensive structured reports with detailed measurements and disease detection. While both are FDA-cleared AI tools for cardiology, they are adjacent rather than direct competitors, as they leverage distinct diagnostic modalities—auscultation and ECG versus ultrasound imaging—to address different stages of cardiac assessment.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Eko Analysis Software analyzes auscultation data, specifically heart sounds and ECGs, captured via Eko's digital stethoscopes. In contrast, Us2.v2 processes echocardiogram images from any ultrasound manufacturer to automate interpretation and reporting.
Eko Analysis Software is FDA-cleared to assist in the early detection of heart murmurs and atrial fibrillation, and also detects normal sinus rhythm and calculates cardiac time intervals. Us2.v2 automates the detection of conditions such as cardiac amyloidosis, aortic stenosis, heart failure, pulmonary hypertension, and valvular disease, delivering these findings within a complete structured echo report.
Eko Analysis Software integrates with Eko's digital stethoscopes and mobile app, offering features like secure cloud storage and telehealth livestreaming with a paid subscription. Us2.v2 is designed to integrate seamlessly with existing PACS, CVIS, or EMR systems, supporting HL7 and DICOM SR, and is compatible with any ultrasound manufacturer.
Eko Analysis Software's primary benefit is assisting clinicians in the early detection of cardiovascular diseases through AI-powered auscultation and ECG analysis. Us2.v2 emphasizes 100% AI automation of echocardiogram interpretation, aiming to eliminate manual frame selection and annotation, and can reduce reporting time by up to 70% while increasing daily scan throughput.